Search

everythinglearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

New compounds may help treat prostate issues without affecting androgen receptors.

Alpha1-blockers effectively improve urinary symptoms in BPH, with alfuzosin and tamsulosin having fewer side effects.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Clascoterone may be an effective topical treatment for hair loss.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

New hybrid compound found to effectively prevent hair loss.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The inhibitor affects androgen metabolism but not ovarian function.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Cortisone suppresses hair regrowth, especially undercoat hair, while adrenalectomy affects hair growth differently in rabbits and rats.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Astressin-B can reverse and prevent hair loss in stressed mice.

Allopregnanolone may help prevent nicotine withdrawal symptoms.